Alberto Pugliese, M.D.

Professor

  • 4028 Citations
1989 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Type 1 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Autoantibodies Medicine & Life Sciences
Pancreas Medicine & Life Sciences
Autoimmunity Medicine & Life Sciences
Autoantigens Medicine & Life Sciences
Alleles Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2020

Serum miRNA Biomarkers of Islet Autoimmunity

Pugliese, A.

National Institutes of Health

3/23/162/29/20

Project: Research projectResearch Project

MicroRNAs
Autoimmunity
Biomarkers
Type 1 Diabetes Mellitus
Serum

Evaluation of MicroRNA Expression in CD4 T cells in Type 1 Diabetes

Pugliese, A.

National Institutes of Health

9/30/068/31/07

Project: Research projectExploratory/Developmental Grants

MicroRNAs
Type 1 Diabetes Mellitus
T-Lymphocytes
Autoantibodies
Autoimmunity

Evaluation of MicroRNA Expression in CD4 T cells in Type 1 Diabetes

Pugliese, A.

National Institutes of Health

9/30/068/31/09

Project: Research projectExploratory/Developmental Grants

MicroRNAs
Type 1 Diabetes Mellitus
T-Lymphocytes
Autoantibodies
Autoimmunity

PROINSULIN EXPRESSION IN THE IMMUNE SYSTEM

Pugliese, A.

National Institutes of Health

9/29/988/31/02

Project: Research projectResearch Project

Proinsulin
Immune System
Thymus Gland
Insulin
Type 1 Diabetes Mellitus

Research Output 1989 2018

5 Citations

Genetics of type 1 diabetes

Redondo, M. J., Steck, A. K. & Pugliese, A., May 1 2018, In : Pediatric Diabetes. 19, 3, p. 346-353 8 p.

Research output: Contribution to journalReview article

Type 1 Diabetes Mellitus
Inborn Genetic Diseases
Insulin-Secreting Cells
Disease Progression
Insulin

IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Churlaud, G., Rosenzwajg, M., Cacoub, P., Saadoun, D., Valteau-Couanet, D., Chaput, N., Pugliese, A. & Klatzmann, D., Jun 2 2018, (Accepted/In press) In : Diabetologia. p. 1-3 3 p.

Research output: Contribution to journalArticle

Type 1 Diabetes Mellitus
Interleukin-2
Antibodies
Therapeutics

Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans

Simeonovic, C. J., Popp, S. K., Starrs, L. M., Brown, D. J., Ziolkowski, A. F., Ludwig, B., Bornstein, S. R., Wilson, J. D., Pugliese, A., Kay, T. W. H., Thomas, H. E., Loudovaris, T., Choong, F. J., Freeman, C. & Parish, C. R., Feb 1 2018, In : PLoS One. 13, 2, e0191360

Research output: Contribution to journalArticle

Heparitin Sulfate
insulin-dependent diabetes mellitus
Medical problems
Type 1 Diabetes Mellitus
Syndecan-2

MicroRNAs: Markers of β-cell stress and autoimmunity

Dotta, F., Ventriglia, G., Snowhite, I. V. & Pugliese, A., Aug 1 2018, In : Current Opinion in Endocrinology, Diabetes and Obesity. 25, 4, p. 237-245 9 p.

Research output: Contribution to journalReview article

MicroRNAs
Autoimmunity
Type 1 Diabetes Mellitus
Biomarkers
Tissue Donors
5 Citations

TCF7L2 genetic variants contribute to phenotypic heterogeneity of type 1 diabetes

Type 1 Diabetes TrialNet Study Group, Feb 1 2018, In : Diabetes Care. 41, 2, p. 311-317 7 p.

Research output: Contribution to journalArticle

T Cell Transcription Factor 1
Type 1 Diabetes Mellitus
Autoantibodies
Type 2 Diabetes Mellitus
Area Under Curve